secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2026-05-13T20:35:45+00:00
Accession:  0001295947-26-000013
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer reports FY26 adj EPS $4.38; acquires LaCorium Health for $150M
--------------------------------------------------------------------------------

- FY26 revenue $1,088.7M (-4.3% YoY); adjusted diluted EPS $4.38 vs $4.52 prior year.
- Q4 revenue $281.6M (-5% YoY); adjusted diluted EPS $1.23 vs $1.32.
- Acquiring LaCorium Health (Australian therapeutic skincare) for ~$150M cash; expected close Q2 FY27.
- LaCorium TTM revenue ~$40M; expected ~$12M EBITDA with synergies.
- FY27 outlook: organic revenue growth 1-3%, adj EPS $4.42-$4.51, FCF $250M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/0001295947-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/pbh-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001295947-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer